68ga-psma
Showing 1 - 8 of 8
Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)
Active, not recruiting
- Prostate Cancer
- High Risk
- 68Ga-PSMA
-
Houston, TexasHouston Methodist
Dec 8, 2022
Malignant Tumor Trial in Wuhan (68Ga-PSMA, PET/MR, PET/CT)
Recruiting
- Malignant Neoplasm
- 68Ga-PSMA
- +2 more
-
Wuhan, Hubei, ChinaChina, Hubei Province
Feb 9, 2022
Renal Cell Carcinoma Trial in Beijing (68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617)
Recruiting
- Renal Cell Carcinoma
- 68Ga-PSMA
- 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Dec 24, 2021
Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Metastatic Trial in Ann Arbor (68Ga-PSMA)
Active, not recruiting
- Prostate Cancer
- +3 more
- 68Ga-PSMA
-
Ann Arbor, MichiganUniversity of Michigan
Mar 10, 2022
Adenoid Cystic Carcinoma Trial in Beijing (68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617)
Recruiting
- Adenoid Cystic Carcinoma
- 68Ga-PSMA
- 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 18, 2021
Prostate Cancer Trial in Houston (68Ga-PSMA)
Recruiting
- Prostate Cancer
- 68Ga-PSMA
-
Houston, TexasRadio- Isotope Therapy of America
Aug 17, 2020
Prostate-specific Membrane Antigen, mCRPC or Advanced/Metastatic Solid Tumors Trial in Meldola (68Ga-PSMA)
Recruiting
- Prostate-specific Membrane Antigen
- mCRPC or Advanced/Metastatic Solid Tumors
- 68Ga-PSMA
-
Meldola, FC, ItalyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumor
Feb 25, 2021